Giulia Grande, MD; Petter L. S. Ljungman, MD, PhD; Kristina Eneroth, PhD; et al.
JAMA Neurol. 2020;77(7):801-809. doi:10.1001/jamaneurol.2019.4914
This cohort study investigates the association of long-term exposure to air pollution with dementia and evaluates the role of cardiovascular disease in the association among participants of the population-based Swedish National Study on Aging and Care in Kungsholmen.
Deborah A. Levine, MD, MPH; Alden L. Gross, PhD; Emily M. Briceño, PhD; et al.
has active quiz
JAMA Neurol. 2020;77(7):810-819. doi:10.1001/jamaneurol.2020.0568
This cohort study assesses whether blood pressure levels are associated with racial differences in cognitive decline.
Raffaele Palladino, PhD; Ruth Ann Marrie, MD, PhD; Azeem Majeed, MD; et al.
JAMA Neurol. 2020;77(7):820-828. doi:10.1001/jamaneurol.2020.0664
This cohort study assesses whether the risk of macrovascular events and mortality differs among people with multiple sclerosis compared with a matched population without multiple sclerosis in England.
Adam S. Fleisher, MD, MAS; Michael J. Pontecorvo, PhD; Michael D. Devous Sr, PhD; et al.
has active quiz
JAMA Neurol. 2020;77(7):829-839. doi:10.1001/jamaneurol.2020.0528
This diagnostic study explores whether positron emission tomography with [18F]flortaucipir can detect tau pathology and Alzheimer disease neuropathologic changes in terminally ill adults with or without dementia.
Christopher I. Price, MD; Lisa Shaw, MD; Saiful Islam, PhD; et al.
JAMA Neurol. 2020;77(7):840-848. doi:10.1001/jamaneurol.2020.0611
This cluster randomized clinical trial sought to examine whether adding enhanced paramedic assessment to standard care would result in increased rates of thrombolysis in patients experiencing stroke.
Michael E. Belloy, PhD; Valerio Napolioni, PhD; Summer S. Han, PhD; et al.
JAMA Neurol. 2020;77(7):849-862. doi:10.1001/jamaneurol.2020.0414
This study combined data from 35 independent case-control, family-based, and longitudinal cohorts that examined Alzheimer disease to determine if Klotho-VS heterozygosity is associated with reduced Alzheimer disease risk and β-amyloid (Aβ) pathology in individuals who carry APOE4.
Andrew D. Wilcock, PhD; Kori S. Zachrison, MD, MSc; Lee H. Schwamm, MD; et al.
JAMA Neurol. 2020;77(7):863-871. doi:10.1001/jamaneurol.2020.0770
This cohort study describes trends among rural and urban patients with acute ischemic stroke or transient ischemic attack in the type of health care centers to which patients were admitted, what care was provided, and patient outcomes.
Audio Author Interview:
Care Delivery and Outcomes for Acute Stroke and Transient Ischemic Attacks in Rural and Urban Medicare Patients